Sibanye Gold Ltd ADR (SBSW)vsVersamet Royalties Corporation Common Stock (VMET)
SBSW
Sibanye Gold Ltd ADR
$13.33
+1.06%
BASIC MATERIALS · Cap: $9.72B
VMET
Versamet Royalties Corporation Common Stock
$10.83
-4.41%
BASIC MATERIALS · Cap: $1.32B
Smart Verdict
WallStSmart Research — data-driven comparison
Sibanye Gold Ltd ADR generates 372953% more annual revenue ($129.68B vs $34.76M). VMET leads profitability with a 58.5% profit margin vs -4.0%. VMET earns a higher WallStSmart Score of 45/100 (D+).
SBSW
Hold40
out of 100
Grade: F
VMET
Hold45
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 31.6% year-over-year
Keeps 59 of every $100 in revenue as profit
Strong operational efficiency at 135.6%
Revenue surging 465.2% year-over-year
Areas to Watch
Grey zone — moderate risk
Elevated debt levels
ROE of -10.2% — below average capital efficiency
Earnings declined 38.2%
0.0% earnings growth
Smaller company, higher risk/reward
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : SBSW
The strongest argument for SBSW centers on Revenue Growth. Revenue growth of 31.6% demonstrates continued momentum.
Bull Case : VMET
The strongest argument for VMET centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 58.5% and operating margin at 135.6%. Revenue growth of 465.2% demonstrates continued momentum.
Bear Case : SBSW
The primary concerns for SBSW are Altman Z-Score, Debt/Equity, Return on Equity.
Bear Case : VMET
The primary concerns for VMET are EPS Growth, Market Cap, P/E Ratio. A P/E of 58.0x leaves little room for execution misses.
Key Dynamics to Monitor
SBSW profiles as a hypergrowth stock while VMET is a growth play — different risk/reward profiles.
VMET is growing revenue faster at 465.2% — sustainability is the question.
VMET generates stronger free cash flow (10M), providing more financial flexibility.
Monitor OTHER PRECIOUS METALS & MINING industry trends, competitive dynamics, and regulatory changes.
Bottom Line
VMET scores higher overall (45/100 vs 40/100), backed by strong 58.5% margins and 465.2% revenue growth. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Sibanye Gold Ltd ADR
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Sibanye Stillwater Limited is a precious metals mining company in South Africa, the United States, Zimbabwe, Canada and Argentina. The company is headquartered in Weltevreden Park, South Africa.
Visit Website →Versamet Royalties Corporation Common Stock
BASIC MATERIALS · OTHER PRECIOUS METALS & MINING · USA
Viamet Pharmaceuticals Corp (VMET) is a biopharmaceutical company focused on developing novel therapeutics for serious and life-threatening diseases, particularly through its innovative drug development platform that leverages its proprietary metalloenzyme-based technology. The company aims to address unmet medical needs in areas such as fungal infections and oncology, positioning itself at the forefront of therapeutic innovation. Viamet's strategic partnerships and strong intellectual property portfolio underscore its commitment to advancing its pipeline while maximizing shareholder value. As it progresses through clinical development phases, VMET stands to play a significant role in transforming treatment paradigms within its targeted therapeutic areas.
Compare with Other OTHER PRECIOUS METALS & MINING Stocks
Want to dig deeper into these stocks?